SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
neuralink
Scale of Musk's DOGE Conflicts of Interest 'Should Alarm Every American'
"The wealthiest man in the world is working to dismantle the very same federal departments and agencies tasked with overseeing and placing checks on his businesses," says Public Citizen in a new analysis.
May 08, 2025
Elon Musk, the world's richest person and de facto head of the Trump administration's so-called Department of Government Efficiency, "has had a direct business interest in over 70% of the agencies and departments targeted by DOGE since its inception," according to an analysis published Thursday by a leading U.S. consumer advocacy group.
The Public Citizen report, titled Duplicitous Oligarchy Grifting Endlessly, "maps out the entities DOGE has targeted and identifies which ones carry a known conflict of interest for Elon Musk's business entanglements" as the executive office leads the Trump administration's purge of federal agencies.
"The wealthiest man in the world is working to dismantle the very same federal departments and agencies tasked with overseeing and placing checks on his businesses," the report states. "He also now is adjacent to and could potentially access sensitive and potentially proprietary information from his biggest competitors in the various industries that have made him wealthy. He also has personal business interests that could shape what his DOGE project considers ripe for cuts."
Elon Musk's DOGE has spent the last several months dismantling the departments & agencies that regulate HIS businesses. Our report found that Musk has a direct business interest in over 70% of the agencies & departments DOGE targeted. The conflicts of interest are endless.
— Public Citizen (@publiccitizen.bsky.social) May 8, 2025 at 11:46 AM
Elizabeth Beavers, director of Public Citizen's Congress Watch, said in a statement that "it should alarm every American that the wealthiest man in the world has spent the last several months dismantling the same departments and agencies tasked with regulating his businesses."
"Musk's role as the most powerful person in government makes it highly unlikely that any regulator will crack down on his corporations and surely will make agency leaders look more favorably at Musk companies as potential government contractors," Beavers added.
The report considers Musk—who has signaled he will leave DOGE—to have a conflict of interest with a federal agency when one of his companies has received contracts or grants from the department, has an interest in its proprietary data, and is subject to its regulation or enforcement regime.
Public Citizen's analysis highlights interests with federal agencies including:
- Consumer Financial Protection Bureau, which Musk wants to abolish, would be in charge of regulating a proposed payments processing partnership between Visa and Musk's social media platform X;
- Department of Justice, which is investigating electric automaker Tesla and possibly Musk as its CEO;
- Federal Aviation Administration, which regulates Musk's SpaceX;
- Food and Drug Administration, where some of the more than 1,000 fired staffers were reviewing Musk's Nueralink brain implants;
- National Aeronautics and Space Administration, which has awarded SpaceX approximately $15 billion in contracts;
- National Highway Traffic Safety Administration, which regulates Teslas, was hit with a 10% workforce reduction since President Donald Trump took office;
- Securities and Exchange Commission, which has ongoing enforcement actions against Musk, including fines as high as $150 million for failing to file disclosure forms regarding shares of Twitter, which he bought in 2022; and
- United States Agency for International Development, which was investigating whether Russia had improperly gained access to Musk's Starlink satellite internet system.
Musk—whose companies have tens of billions of dollars worth of government contracts—also has conflicts of interest with the departments of Defense, Agriculture, and Energy. SpaceX, for example, holds Pentagon contracts worth around $8 billion, including nearly $6 billion for the National Security Space Launch Phase 3 Lane 2 program.
Critics have laughed off the White House's assertion that Musk would self-police his conflicts of interest by recusing himself when DOGE and his business interests overlap.
"The report's findings make clear that this approach is deeply and incurably flawed—and that urgent action by Congress is required to safeguard the government from Musk's self-dealing and grift," Public Citizen said.
Keep ReadingShow Less
'Blatant Conflict': Fired FDA Workers Were Reviewing Musk's Neuralink
"DOGE operatives should stop interfering with the FDA's public health mission of assuring the safety and effectiveness of drugs and medical devices," said a doctor at one watchdog group.
Feb 19, 2025
A U.S. watchdog group and other critics are responding with alarm to reporting that federal employees reviewing applications related to a brain implant developed by Elon Musk's company Neuralink are among those fired as part of the billionaire and President Donald Trump's sweeping mission to gut the government workforce.
Despite business conflicts and a recent White House court declaration that generated some confusion, Musk is the head of Trump's so-called Department of Government Efficiency (DOGE), which has infiltrated and is working to purge employees from several agencies—including the U.S. Food and Drug Administration (FDA), according toReuters.
Citing two unnamed sources, the news agency reported Monday that "the cuts included about 20 people in the FDA's Office of Neurological and Physical Medicine Devices, several of whom worked on Neuralink... That division includes reviewers overseeing clinical trial applications by Neuralink and other companies making so-called brain-computer interface devices."
While the sources "said they did not believe the employees were specifically targeted because of their work on Neuralink's applications," they and other experts warned the firings "will hamper the agency's ability to quickly and safely process medical device applications of all sorts," Reuters noted.
Dr. Robert Steinbrook, director of Public Citizen's Health Research Group, said in Wednesday statement that "regardless of the reasons the FDA medical device center employees were fired, Elon Musk and the so-called Department of Government Efficiency have a blatant conflict of interest because the agency's Center for Devices and Radiological Health is regulating the implantable brain-computer interface made by one of Musk's companies."
"Moreover, by eviscerating the FDA's device staff, DOGE operatives are impeding the vital work of protecting the participants in the Neuralink trial and protecting the public from medical devices that are harmful or don't work," he continued. "Paradoxically, with fewer staff, the FDA's review of the Neuralink device may be impeded, which makes no sense."
"DOGE operatives should stop interfering with the FDA's public health mission of assuring the safety and effectiveness of drugs and medical devices," Steinbrook added. "This is yet the latest example of how Musk's involvement with DOGE undermines federal regulators, from the Consumer Financial Protection Bureau to the FDA."
Various reports from the past month have highlighted how Trump's return to power has benefited Musk and his businesses, including SpaceX and the publicly traded electric vehicle maker Tesla.
As Gizmododetailed Tuesday:
Neuralink in particular seems to have benefited from efforts to squash watchdogs. Last month, the inspector general at the U.S. Department of Agriculture had to be removed from her office by security after refusing to comply with her termination, which she believed was illegal. She happened to be heading up an investigation into Neuralink looking into whether the company was violating animal welfare rules related to its tests on animal subjects.
The FDA, too, has been looking into similar issues. Last year, the agency found that Neuralink's animal labs engaged in "objectionable conditions or practices" and urged the company to address the issues—but did not issue any punitive actions related to the investigation.
Neuralink and the FDA also had a standoff over allowing the company to move forward with human trials, a request that the FDA rejected over safety risks in 2022 before finally allowing limited trials to move forward a year later. In 2024, the FDA even gave Neuralink its "breakthrough device" designation, which allows for a speedier review process. The only thing faster might be no review at all.
A Quinnipiac University national poll released Wednesday shows that 50% of registered voters across the political spectrum have an unfavorable opinion of Musk, 54% disapprove of the richest person on Earth "playing a prominent role in the Trump administration," and 55% think he "has too much power in making decisions affecting the United States."
Keep ReadingShow Less
Ethics Group Asks SEC to Probe Musk Claims About 'Gruesome' Neuralink Monkey Trials
"It seems obvious to everyone but Elon Musk that Neuralink's device is unsafe," said one critic. "Now he is deliberately misleading investors and the public by outright lying about the company's monkey experiments."
Sep 21, 2023
After obtaining records showing a dozen monkeys were euthanized in "gruesome" trials, a national physicians group on Wednesday asked the U.S. Securities and Exchange Commission to investigate claims made by Elon Musk, owner of the biotech firm Neuralink, about the company's experimental brain implants.
Physicians Committee for Responsible Medicine (PCRM) requested an SEC probe into possible securities fraud committed by Musk when he claimed that "no monkey has died as a result of a Neuralink implant" during testing of the company's implantable brain-computer interfaces (BCI), and that the animals who died were all already terminally ill when chosen for experiments.
However, records obtained by PCRM and WIRED revealed that 12 previously healthy Rhesus macaques were euthanized by Neuralink due to problems with the company's implant. Health records offer no evidence that the 12 monkeys were terminally ill, as Musk claimed. Rhesus macaques commonly live around 20 years in captivity, with some reaching the age of 40. The average age of the 12 monkeys who died during Neuralink experiments was 7.25 years.
"It seems obvious to everyone but Elon Musk that Neuralink's device is unsafe and dangerous," PCRM research and advocacy director Ryan Merkley said in a statement. "Now he is deliberately misleading investors and the public by outright lying about the company's monkey experiments."
Veterinary records paint what WIREDcalled a "gruesome portrayal" of suffering endured by monkeys during Neuralink trials.
PCRM recounted the story of "Animal 15," a 6-year-old female Rhesus macaque assigned to Neuralink trials at the California National Primate Research Center (CNPRC) at the University of California, Davis in September 2017. The following spring, she began "task training," during which the animal is confined in a restraint device. She did not take well to the training and refused to eat. Then she and another monkey escaped from their cages.
On December 17, 2018, "Neuralink staff drilled holes into Animal 15's skull, removed part of her skull and skin to expose her brain, and implanted two electrodes, one in each hemisphere of her brain. The surgery lasted five hours."
According to research records, Animal 15 developed a host of medical problems, including excessive itching, bloody discharge, and loss of balance. She was repeatedly observed pulling on the port connector in her skull and was seen pressing her head against the floor, a possible sign of pain or neurological impairment.
On Christmas 2018, Animal 15 was seen "pulling and picking at the incision sites." Both of her eyes were swollen half-shut. By March, large quantities of discharge were observed coming from Animal 15's head; lab tests showed multiple bacterial infections on her implants. Her health declined until she was euthanized on March 21, 2019.
"A necropsy found that the Neuralink implants left parts of Animal 15's brain 'focally tattered,' that 'remnant electrode threads' were found in her brain, and there were indications of hemorrhaging," PCRM said.
In the case of "Animal 22," a monkey euthanized in March 2020, a necropsy report states that "the failure of this implant can be considered purely mechanical and not exacerbated by infection," an apparently direct contradiction of Musk's claim that no animals died from Neuralink implants.
A former Neuralink employee, who did not want to be named for fear of retaliation, told WIRED that Musk's claim is "ridiculous" and "straight fabrication."
A doctoral candidate currently researching at CNPRC—who also requested anonymity for similar reasons—told the outlet that "these are pretty young monkeys."
"It's hard to imagine these monkeys, who were not adults, were terminal for some reason," the researcher added.
As WIRED reported Wednesday:
If the SEC does investigate Musk's comments, it would mark at least the third federal probe linked to Neuralink's animal testing. In December 2022, Reutersreported that the U.S. Department of Agriculture's Office of Inspector General had launched a probe into Neuralink's treatment of some animal test subjects. In February 2023, the U.S. Department of Transportation opened an investigation into Neuralink over allegations of unsafe transport of antibiotic-resistant pathogens.
These investigations followed the U.S. Food and Drug Administration initially rejecting Neuralink's application, in early 2022, for approval to conduct in-human clinical trials. According toReuters, the agency's major concerns involved the device's lithium battery, as well as the possibility that the implant's wires might migrate to other parts of the brain.
Despite this, the FDA in May gave Neuralink the green light to begin human trials. On Wednesday, the company announced it would start recruiting adults with quadriplegia due to vertical spinal cord injury or amyotrophic lateral sclerosis—ALS, or Lou Gehrig's disease—for trials.
Called the PRIME study, the trials will test Neuralink's ability to help people with paralysis control devices. The company said Wednesday that it aims to "grant people the ability to control a computer cursor or keyboard using their thoughts alone."
In 2018, the SEC charged Musk with securities fraud for a series of false and misleading posts on Twitter—which he later bought and rebranded as X—about potentially taking his electric car company Tesla private. In a settlement, Musk agreed to resign as Tesla's chairman and pay a $20 million penalty. The company was also hit with a $20 million fine.
Keep ReadingShow Less
Most Popular